The Cancer Vaccine That Could Save Moderna

0:00-25:55

For years, Moderna was a one-hit wonder, a company that bet everything on mRNA, struck gold with a COVID vaccine and then watched its stock crater as the pandemic faded. Now, the company may have found a way to fight skin cancer. An experimental mRNA-based vaccine succeeded in preventing melanoma from returning in high-risk patients, sending drug industry stocks soaring. WSJ’s Xavier Martinez traces Moderna’s wild ride from scrappy startup to the frontier of cancer treatment. Ryan Knutson hosts. Further Listening: - The FDA Commissioner on Vaccines and Public Trust - The Creator of the Record-Setting Covid Vaccine Sign up for WSJ’s free What’s News newsletter.

Publisher

The Journal.

Published

August 28, 2026

Duration

26 min

Format

Podcast

Category

News · Daily News

Source

RSS feed

Host

The Wall Street Journal & Spotify Studios

TJ

The Journal.

@thejournalwsj

#cancervaccine #savemoderna

The Nile